AK5
Adenylate kinase isoenzyme 5
Also known as: KAD5_HUMAN
Cross-references: UniProt · Ensembl · Human Protein Atlas · GeneCards · NCBI Gene
Protein identityUniProt · HPA
- UniProt accession
- Q9Y6K8
- Gene
- AK5
- Ensembl
- ENSG00000154027
- Chromosome
- 1
- Canonical length
- 562 aa
- Protein class
- Enzymes, Metabolic proteins, Predicted intracellular proteins
- Subcellular location
- Centriolar satellite,Cytosol
OverviewNCBI Gene
This gene encodes a member of the adenylate kinase family, which is involved in regulating the adenine nucleotide composition within a cell by catalyzing the reversible transfer of phosphate groups among adenine nucleotides. This member is related to the UMP/CMP kinase of several species. It is located in the cytosol and expressed exclusively in brain. Alternatively spliced transcript variants encoding distinct isoforms have been identified for this gene. [provided by RefSeq, Jul 2008]
Canonical amino-acid sequenceUniProt
562 residues, UniProt reviewed canonical sequence.
>Q9Y6K8|AK5
1 MNTNDAKEYL ARREIPQLFE SLLNGLMCSK PEDPVEYLES CLQKVKELGG CDKVKWDTFV
61 SQEKKTLPPL NGGQSRRSFL RNVMPENSNF PYRRYDRLPP IHQFSIESDT DLSETAELIE
121 EYEVFDPTRP RPKIILVIGG PGSGKGTQSL KIAERYGFQY ISVGELLRKK IHSTSSNRKW
181 SLIAKIITTG ELAPQETTIT EIKQKLMQIP DEEGIVIDGF PRDVAQALSF EDQICTPDLV
241 VFLACANQRL KERLLKRAEQ QGRPDDNVKA TQRRLMNFKQ NAAPLVKYFQ EKGLIMTFDA
301 DRDEDEVFYD ISMAVDNKLF PNKEAAAGSS DLDPSMILDT GEIIDTGSDY EDQGDDQLNV
361 FGEDTMGGFM EDLRKCKIIF IIGGPGSGKG TQCEKLVEKY GFTHLSTGEL LREELASESE
421 RSKLIRDIME RGDLVPSGIV LELLKEAMVA SLGDTRGFLI DGYPREVKQG EEFGRRIGDP
481 QLVICMDCSA DTMTNRLLQR SRSSLPVDDT TKTIAKRLEA YYRASIPVIA YYETKTQLHK
541 INAEGTPEDV FLQLCTAIDS IFLocalizationUniProt · AlphaFold · HPA
Whether an antibody against AK5 can act on the native protein depends on physical access: surface and secreted proteins are reachable by circulating antibodies, intracellular proteins usually are not.
- Antibody reachability
- Intracellular
- Secreted
- No
- Transmembrane segments
- 0
- Mean surface accessibility (rSASA)
- 0.37
- Highest tissue expression
- 125 nTPM
Expression across tissuesHPA
Tissue
- cerebral cortex: 125 nTPM
- hippocampal formation: 84 nTPM
- basal ganglia: 82 nTPM
- amygdala: 74 nTPM
- spinal cord: 40 nTPM
- midbrain: 32 nTPM
Single-cell type
- oligodendrocytes: 865 nCPM
- brain excitatory neurons: 371 nCPM
- brain inhibitory neurons: 247 nCPM
- pituicytes/fscs: 239 nCPM
- breast secretory cells: 205 nCPM
- breast hormone-responsive cells: 184 nCPM
Immune cell
- naive CD4 T-cell: 16 nTPM
- myeloid DC: 14 nTPM
- naive CD8 T-cell: 9.2 nTPM
- gdT-cell: 3.9 nTPM
- memory CD4 T-cell: 3.7 nTPM
- total PBMC: 2.3 nTPM
Brain region
- hippocampal formation: 274 nTPM
- cerebral cortex: 274 nTPM
- basal ganglia: 208 nTPM
- white matter: 187 nTPM
- amygdala: 181 nTPM
- thalamus: 90 nTPM
DiseaseUniProt · ClinVar · IEDB · PubMed
Four sources answering four different questions about AK5.
Disease | AutoantibodyPubMed
Conditions in which antibodies against AK5 are reported. Each links to that disease's full target list.
ReferencesPubMed · IEDB
Publications for AK5 from three distinct lines of evidence, kept separate because they answer different questions: whether antibodies are directed at the protein, whether a B-cell epitope has been mapped on it, and whether a T-cell epitope has. Each is labelled with its source.
Reference: AutoantibodyPubMed
3 publications
- Adenylate kinase 5 autoimmunity in treatment refractory limbic encephalitis.
2007 · J Neuroimmunol · RCR 1.2 · 46 citations - Identification of adenylate kinase 5 antibodies during routine diagnostics in a tissue-based assay: Three new cases and a review of the literature.
2019 · J Neuroimmunol · RCR 0.8 · 15 citations - Clinico-pathological correlation in adenylate kinase 5 autoimmune limbic encephalitis.
2015 · J Neuroimmunol · RCR 0.8 · 24 citations
Sources: PubMed — antigen-level antibody evidence from a custom retrieval. Records matching a controlled set of autoantibody terms (the MeSH descriptors Autoantibodies and Autoantigens, with title and abstract term variants) were obtained through NCBI E-utilities, and their titles and abstracts parsed for constructions that direct an antibody at a named protein rather than for co-occurrence. Captured names were resolved against UniProt nomenclature and each antigen adjudicated individually against the source text. Bibliographic records from PubMed and MeSH, U.S. National Library of Medicine; citation metrics from NIH iCite (Hutchins et al., PLoS Biology 2016). Titles link to PubMed; abstracts are not reproduced here. The NLM does not endorse this analysis.
Genetic constraint and essentialitygnomAD · DepMap
Does the body need this protein intact? Low LOEUF or a strong DepMap dependency means loss or blockade of the protein is likely to be felt.
- gnomAD LOEUF (loss-of-function intolerance)
- 0.56
- gnomAD pLI
- 0
- gnomAD missense Z
- 2.15
- DepMap mean gene effect
- 0.04
- DepMap dependency class
- selective
Cancer expressionTCGA
Across TCGA tumor cohorts, this protein is over-expressed in roughly 4% of surveyed tumor types (aggregate summary; per-cohort expression, alteration, and survival load in the interactive view).
OntologyGO
Biological processes
- ADP biosynthetic process
- ATP metabolic process
- pyrimidine ribonucleotide biosynthetic process
- dADP biosynthetic process
Molecular functions
Cellular components
Protein domainsUniProt · Pfam · InterPro
KeywordsUniProt
InteractionsUniProt · HPA
Protein binding partners of AK5 in the human serome: UniProt-annotated complex subunits plus reported interactors. Each links to its own Seroatlas record.
Antibody and autoantibody relevanceSeroatlas analysis
Seroatlas reads AK5 as an antibody target. Whether an autoantibody or antibody against AK5 could matter depends on whether native AK5 is physically reachable, whether the body needs it intact, and whether it acts in a disease-relevant tissue.
AK5 is annotated as predominantly intracellular. Intracellular proteins are common autoantibody markers, becoming visible to the immune system after cell injury or altered processing, but are usually markers of disease rather than direct drivers.
Annotation status
The present source text does not explicitly label AK5 as an autoantigen. Seroatlas presents hypothesis context only and does not manufacture a known-serology claim.
Loading the interactive Seroatlas protein explorer...